Airdate: Thursday, June 29, 2023 Season: 10 Episode: 18
Guests: Andrew Gaffney, Erin Knock
Dr. Andrew Gaffney and Dr. Erin Knock from STEMCELL Technologies answer questions from a recent webinar where they present a standardized stem cell line and its differentiation into neural cells for disease modeling and assay development.
Associated Webinar: Fully Characterized, Standardized Human Induced Pluripotent Stem Cell Line and Ready-to-Use, High-Quality Neural Progenitor Cells for Downstream Differentiation Applications
Similar Podcasts
Industry Insights with Bas Trietsch and STEMCELL Technologies
Drs. Jenna Moccia and Bas Trietsch explore how stem cell-based models are transforming drug discovery and preclinical research.
#ExpertAnswers: Jack Vanden Heuvel on Prediction Drug-Drug Interactions Early
Dr. Jack Vanden Heuvel from Penn State University and INDIGO Biosciences answers questions from a recent webinar where he discusses methodologies for predicting drug-drug interactions using in vitro assays and gene expression studies.
#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8⁺ T Cell Co-culture Experiments
Dr. Catherine Ewen from STEMCELL Technologies answers questions from a recent webinar where she describes how to set up DC and CD8⁺ T cell co-culture experiments and assess T cell proliferation and activity.